日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally

欧洲药品管理局在新冠疫苗安全监测中的作用以及未来在全球范围内加强疫苗安全性的方向

Caplanusi, Irina; Szmigiel, Agnieszka; van der Elst, Menno; Schougaard Christiansen, Marie Louise; Thirstrup, Steffen; Zaccaria, Cosimo; Cappelli, Bénédicte; Genov, Georgy; Straus, Sabine

Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients

皮内注射mRNA疫苗作为免疫功能低下患者T细胞免疫的替代标志物

Fallet, Benedict; Foglierini, Mathilde; Porret, Raphael; Alcaraz-Serna, Ana; Sauvage, Christophe; Jenelten, Raphael; Caplanusi, Teofila; Gilliet, Michel; Perez, Laurent; Fenwick, Craig; Genolet, Raphael; Harari, Alexandre; Bobisse, Sara; Gottardo, Raphael; Pantaleo, Giuseppe; Muller, Yannick D

A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants

一项 III 期随机、开放标签、非劣效性临床试验,比较口服减毒活人轮状病毒疫苗 (HRV) 的液体制剂和冻干制剂在印度婴儿中的疗效。

Cohet, Catherine; Cheuvart, Brigitte; Moerman, Leentje; Bi, Dan; Caplanusi, Adrian; Kariyappa, Mallesh; Lalwani, Sanjay; Mitra, Monjori; Sapru, Amita; Saha, Shruti; Varughese, P V; Kompithra, Rajeev Zachariah; Gandhi, Sanjay

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study

麻疹-腮腺炎-风疹疫苗作为12至15月龄儿童首剂接种的免疫原性和安全性:一项III期随机、非劣效性、批间一致性研究

Klein, Nicola P; Abu-Elyazeed, Remon; Povey, Michael; Macias Parra, Mercedes; Diez-Domingo, Javier; Ahonen, Anitta; Korhonen, Tiina; Tinoco, Juan-Carlos; Weiner, Leonard; Marshall, Gary S; Silas, Peter E; Sarpong, Kwabena O; Ramsey, Keith P; Fling, John A; Speicher, David; Campos, Maribel; Munjal, Iona; Peltier, Christopher; Vesikari, Timo; Baccarini, Carmen; Caplanusi, Adrian; Gillard, Paul; Carryn, Stephane; Henry, Ouzama

Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates

腮腺炎病毒特异性抗体的评估:斑块减少中和试验与酶联免疫吸附试验估计值的比较

Stéphanie Ravault, Damien Friel, Emmanuel Di Paolo, Adrian Caplanusi, Paul Gillard, Michael Povey, Stephane Carryn

Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study

对7岁及以上健康受试者接种第二剂麻疹-腮腺炎-风疹疫苗的免疫原性和安全性:一项III期随机研究

Abu-Elyazeed, Remon; Jennings, William; Severance, Randall; Noss, Michael; Caplanusi, Adrian; Povey, Michael; Henry, Ouzama

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies

对婴幼儿、儿童和青少年接种两剂AS03佐剂A(H1N1)pdm09大流行性流感疫苗后诱导的体液和细胞免疫反应的安全性和持久性:两项开放性、非对照研究

Garcia-Sicilia, José; Arístegui, Javier; Omeñaca, Félix; Carmona, Alfonso; Tejedor, Juan C; Merino, José M; García-Corbeira, Pilar; Walravens, Karl; Bambure, Vinod; Moris, Philippe; Caplanusi, Adrian; Gillard, Paul; Dieussaert, Ilse

An assessment of prime-boost vaccination schedules with AS03A -adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults

对使用AS03A佐剂的大流行前H5N1疫苗进行初免-加强免疫接种方案的评估:一项针对欧洲成年人的随机研究

Gillard, Paul; Caplanusi, Adrian; Knuf, Markus; Roman, François; Walravens, Karl; Moris, Philippe; Dramé, Mamadou; Schwarz, Tino F

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

AS03佐剂H1N1流感疫苗在儿童中具有延长抗原保护作用的潜力,以及两种AS03佐剂H1N1流感疫苗制剂的免疫学等效性:两项随机试验的结果

Launay, Odile; Duval, Xavier; Fitoussi, Serge; Jilg, Wolfgang; Kerdpanich, Angkool; Montellano, May; Schwarz, Tino F; Watanveerade, Veerachai; Wenzel, Jürgen J; Zalcman, Gerard; Bambure, Vinod; Li, Ping; Caplanusi, Adrian; Madan, Anuradha; Gillard, Paul; Vaughn, David W

Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial

AS03A佐剂甲型H1N1流感疫苗接种间隔的灵活性在18-60岁和60岁以上成人中的应用:一项随机试验

Duval, Xavier; Caplanusi, Adrian; Laurichesse, Henri; Deplanque, Dominique; Loulergue, Pierre; Vaman, Tejaswini; Launay, Odile; Gillard, Paul